India Serological Testing Market Is Expected to reach US$ 813.6 million in 2030

PRESS RELEASE
Published February 22, 2023

The India Serological Testing Market is experiencing significant growth, driven by the increasing prevalence of infectious diseases and advancements in diagnostic technologies. Our comprehensive analysis provides insights into key players, market trends, and innovations, empowering you to make informed decisions and capitalize on emerging opportunities in this dynamic industry. Stay ahead of the curve and gain a competitive edge with our expert analysis of this thriving market.

India’s market for serological testingwas worth191.4 million USDin 2020. The market is anticipated to increase at aCAGR of 16.1%between 2021 and 2030, rising fromUSD 212.1 million in 2021toUSD 813.6 million in 2030. The COVID-19 pandemic has had an unprecedented and staggering impact on the world, with serological testing experiencing a decline in demand across India. According to our analysis, the Indian market will experience a significant drop of -15.2% in 2020. The market’s growth and demand returning to pre-pandemic levels after the pandemic is over is what caused the abrupt increase in CAGR.

Therefore, it is evident that the aforementioned factors, such as the rising incidence of infectious diseases, rising public awareness, and the introduction of new, highly advanced products, will result in promising growth prospects during the forecast period.

Ask for In-depth Report Sample:https://www.fortunebusinessinsights.com/enquiry/sample/india-serological-testing-market-106621

Market Growth Drivers:

Technologically advanced medical devices such as serological test equipment are used for the detection of antibodies in the blood that occurs after an immune response and thus is used to diagnose different disease conditions. This diagnostic procedure provides highly efficient real-time results. Furthermore, these tests are also used in blood banks for the detection of infections like HIV, HCV, HBV, syphilis and malaria in blood or blood products. Serological tests are also used for blood group typing before any blood transfusion process.

Report and Research

  • We utilize data from the demand and supply side and paid databases. All the sources and methodologies adopted for gathering data and information are mentioned in our reports.
  • we provide customization of reports based on your requirements. It will be charged based on the scope of customization. In addition.
  • we provide data for a particular country and region in our reports as well as customized formats. In our reports, we cover major countries and regions. However, if there is a requirement for a specific region, we would be happy to offer the data.
  • we provide market share information and insights considering the scope. This service is provided as a part of customization requirements.
  • we provide particular chapters of the report.

STATISTICAL ANALYSIS

The data is generally gathered in various arrangements such as charts, graphs, infographics, trends, documents and records from various manufacturers and retailers. Our subject experts gather, collect, and interpret such data to form significant databases. Our team then works with large data volumes to analyze core developments, evaluate market estimations, and identify trends.

We provide statistical modelling, inferential statistical analysis, descriptive statistical analysis, and predictive analysis among various other types of studies. Thus, we provide customized reports with data preparation, management, and analysis. We also have a continuous feedback system, wherein our team ensures that new market developments are accurately incorporated in the previous databases.

To Get This Report Customized, Visit:https://www.fortunebusinessinsights.com/enquiry/customization/india-serological-testing-market-106621

Who are the Major India Serological Testing Market Vendors?

  • F. Hoffmann-La Roche Ltd(Basel, Switzerland)
  • Abbott (Abbott Park, U.S.)
  • Thermo Fisher Scientific, Inc. (Waltham, U.S.)
  • Beckman Coulter, Inc.(Danaher) (Brea, U.S.)
  • Tulip Diagnostics (P) Ltd (PerkinElmer Inc.) (Bambolim, India)
  • Eurofins Scientific (Luxembourg, Luxembourg)
  • DiaSorin S.p.A (Saluggia, Italy)
  • Grifols, S.A. (Barcelona, Spain)
  • Siemens Healthineers AG(Munich, Germany)
  • Mylab Discovery Solutions Pvt. Ltd. (Lonavla, India)
  • Ortho-Clinical Diagnostics (Raritan, U.S.)

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favourable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research and development, and new product introduction strategies to execute further business expansion and growth during a forecast period [2022 2029].

Get Quote:https://www.fortunebusinessinsights.com/enquiry/get-a-quote/india-serological-testing-market-106621

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth.Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
US:
+1 424 253 0390
UK:+44 2071 939123
APAC:+91 744 740 1245
Email:sales@fortunebusinessinsights.com

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit India Serological Testing Market Is Expected to reach US$ 813.6 million in 2030

TheExpressWire